Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$38.4M Buy
297,798
+17,559
+6% +$2.3M 0.03% 615
2014
Q2
$37.2M Sell
280,239
-25,845
-8% -$3.39M 0.03% 573
2014
Q1
$40.1M Sell
306,084
-3,573
-1% -$463K 0.04% 476
2013
Q4
$40.3M Sell
309,657
-26,756
-8% -$3.34M 0.04% 475
2013
Q3
$40.4M Buy
336,413
+29,959
+10% +$3.56M 0.04% 407
2013
Q2
$35.3M Buy
+306,454
New +$34.9M 0.04% 426

Other funds holding PX

UBS's PX Position: Q3 2014 in Review

UBS increased its Praxair Inc (PX) stake by 6.3% in Q3 2014, buying an estimated $2.3M and bringing the position to 297,798 shares worth $38.4M. The position accounts for 0.03% of the portfolio, ranked #615.

UBS first reported a position in PX in Q2 2013 and has held it in 6 quarters since. The position peaked at $40.4M in Q3 2013. 886 funds tracked by Wall St. Rank hold PX as of Q3 2014.

  • UBS held 297,798 shares of Praxair Inc worth $38.4M as of Q3 2014.
  • UBS bought 17,559 Praxair Inc shares in Q3 2014, an estimated $2.3M.
  • Praxair Inc made up 0.03% of UBS's portfolio in Q3 2014, its #615 holding.
  • UBS first reported a position in Praxair Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Praxair Inc position peaked at $40.4M in Q3 2013.
  • 886 funds tracked by Wall St. Rank held Praxair Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.